Rx Name [ZUCLOPENTHIXOL, 28160832]

CLOPIXOL 10MG TAB (LUN/COL) ZUCLOPENTHIXOL
28160832
THIOXANTHENES
Cardiac Glycosides

These have a positive inotropic effect and reduce the size of a failing dilated heart leading to increased cardiac output and increased efficiency. They increase myocardial excit-ability and automaticity, depress conducting tissue and increase vagal activity. Digoxin’s half-life is more than 24 hours. The therapeutic blood level is 0.8 to 2.0mg/ml.

General Indications
(Digoxin)

Cardiac failure, atrial fibrillation, atrial flutter, paroxysmal atrial tachcardia.

Cautions/Side Effects
(Digoxin)

These usually occur at toxic serum levels above 2.0 mg/ml, but may do so in the therapeutic range especially in the elderly. Fatigue, anorexia,



nausea, visual disturbances, muscle weakness, psychic symptoms, abdominal pain, dizziness, vomiting, cardiacdisturbance - heart block,cardiac arrhythmias. Tocicity most likely with hypokalemia. Treat digoxin - induced heart block with atropine; PVC’s and ventricular tachycardia with i.v. phenytoin. These drugs must be used with caution:


(1) following acute myocar-dial infarction;

(2) within 14 days of previous treatment with cardiac glycosides;

(3) in the presence of Quinidine treatment;

(4) in the presence of severe potassium imbalance;

(5) in renal insufficiency and in the elderly (most of whom have some renal impairment).


Dose Range (Digoxin)

Loading dose 0.75 - 1.5mg in first day (e.g. 0.5mg initially and 0.25mg every 6 - 8 hours until desirable effect is reached or toxicity occurs). Maintenance dose 0.125 - 0.25mg.

Children - oral: 25 - 35 mcg/kg every 6 hours until digitalization, then 25 - 35% of loading dose for maintenance.

Anti-Arrhythmics

The physiology of arrhythmias is complex and the action of drugs used in their treatment equally so.

CLASS I - Membrane stabilizers

CLASS II - Drugs which reduce sym-pathetic activity

CLASS III - Drugs which prolong the effective refractory period and duration of the action potential

CLASS IV - Drugs which interfere with calcium transfer into the cell